Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 1
1968 1
1972 1
1988 3
1989 3
1990 3
1991 3
1992 6
1993 5
1994 3
1995 5
1996 4
1997 6
1998 3
1999 5
2000 4
2001 3
2002 7
2003 11
2004 7
2005 10
2006 10
2007 15
2008 11
2009 7
2010 14
2011 16
2012 7
2013 13
2014 14
2015 21
2016 15
2017 10
2018 17
2019 24
2020 25
2021 25
2022 33
2023 31
2024 35

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

396 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators. Perkovic V, et al. N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14. N Engl J Med. 2019. PMID: 30990260 Free article. Clinical Trial.
Sodium Intake and Chronic Kidney Disease.
Borrelli S, Provenzano M, Gagliardi I, Michael A, Liberti ME, De Nicola L, Conte G, Garofalo C, Andreucci M. Borrelli S, et al. Among authors: de nicola l. Int J Mol Sci. 2020 Jul 3;21(13):4744. doi: 10.3390/ijms21134744. Int J Mol Sci. 2020. PMID: 32635265 Free PMC article. Review.
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial.
Provenzano M, Puchades MJ, Garofalo C, Jongs N, D'Marco L, Andreucci M, De Nicola L, Gorriz JL, Heerspink HJL; ROTATE-3 study group; ROTATE-3 study group members. Provenzano M, et al. Among authors: de nicola l. J Am Soc Nephrol. 2022 Aug;33(8):1569-1580. doi: 10.1681/ASN.2022020207. Epub 2022 Apr 19. J Am Soc Nephrol. 2022. PMID: 35440501 Free PMC article. Clinical Trial.
Reply.
Moore CL, Baskin A, Cheung D, Davis MA, Fertel BS, Larson DM, Lee RK, McCabe-Kline KB, Mills AM, Nicola GN, Nicola LP. Moore CL, et al. Among authors: nicola lp. J Am Coll Radiol. 2023 Dec;20(12):1191-1192. doi: 10.1016/j.jacr.2023.06.002. Epub 2023 Jun 20. J Am Coll Radiol. 2023. PMID: 37348746 No abstract available.
Hyperkalemia in CKD: an overview of available therapeutic strategies.
Costa D, Patella G, Provenzano M, Ielapi N, Faga T, Zicarelli M, Arturi F, Coppolino G, Bolignano D, De Sarro G, Bracale UM, De Nicola L, Chiodini P, Serra R, Andreucci M. Costa D, et al. Among authors: de nicola l. Front Med (Lausanne). 2023 Jul 31;10:1178140. doi: 10.3389/fmed.2023.1178140. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37583425 Free PMC article. Review.
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
Chertow GM, Pergola PE, Farag YMK, Agarwal R, Arnold S, Bako G, Block GA, Burke S, Castillo FP, Jardine AG, Khawaja Z, Koury MJ, Lewis EF, Lin T, Luo W, Maroni BJ, Matsushita K, McCullough PA, Parfrey PS, Roy-Chaudhury P, Sarnak MJ, Sharma A, Spinowitz B, Tseng C, Tumlin J, Vargo DL, Walters KA, Winkelmayer WC, Wittes J, Eckardt KU; PRO2TECT Study Group. Chertow GM, et al. N Engl J Med. 2021 Apr 29;384(17):1589-1600. doi: 10.1056/NEJMoa2035938. N Engl J Med. 2021. PMID: 33913637 Clinical Trial.
New trials in resistant hypertension: mixed blessing stories.
Zoccali C, Mallamaci F, De Nicola L, Minutolo R. Zoccali C, et al. Among authors: de nicola l. Clin Kidney J. 2023 Sep 27;17(1):sfad251. doi: 10.1093/ckj/sfad251. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186891 Free PMC article. Review.
396 results